Landos Biopharma, Inc.

Report date

3/31/2023

Quarter

2023 Q1

Filed

6/1/2023

147,182

Value ($000)

Weight

0.0%

2021 Q1 - 2023 Q1 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	6/1/2023	44	0.0%	147,182	3/31/2023
2022 Q4	2/21/2023	74	0.0%	147,182	12/31/2022
2022 Q3	11/14/2022	96	0.0%	147,182	9/30/2022
2022 Q2	8/17/2022	107	0.0%	147,182	6/30/2022
2022 Q1	5/16/2022	217	0.0%	147,182	3/31/2022
2021 Q4	2/11/2022	706	0.0%	147,182	12/31/2021
2021 Q3	11/12/2021	2,149	0.0%	147,182	9/30/2021
2021 Q2	8/13/2021	1,700	0.0%	147,182	6/30/2021
2021 Q1	5/14/2021	1,417	0.0%	147,182	3/31/2021